APA (7th ed.) Citation

Longuespée, R., Kunz, J., Fresnais, M., Foerster, K., Burhenne, J., Thomas, M., . . . Haefeli, W. E. (2024). Therapeutic drug monitoring of osimertinib in non-small cell lung cancer and short bowel syndrome: A case report. British journal of clinical pharmacology, 90(1), . https://doi.org/10.1111/bcp.15924

Chicago Style (17th ed.) Citation

Longuespée, Rémi, et al. "Therapeutic Drug Monitoring of Osimertinib in Non-small Cell Lung Cancer and Short Bowel Syndrome: A Case Report." British Journal of Clinical Pharmacology 90, no. 1 (2024). https://doi.org/10.1111/bcp.15924.

MLA (9th ed.) Citation

Longuespée, Rémi, et al. "Therapeutic Drug Monitoring of Osimertinib in Non-small Cell Lung Cancer and Short Bowel Syndrome: A Case Report." British Journal of Clinical Pharmacology, vol. 90, no. 1, 2024, https://doi.org/10.1111/bcp.15924.